Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178705 (CHEMBL3814804) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50398334 (CHEMBL2178578) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid PDB UniChem | PDB Article PubMed | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178714 (CHEMBL3814136) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178704 (CHEMBL3814736) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178716 (CHEMBL3814511) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 29 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178707 (CHEMBL3814811) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178712 (CHEMBL3813888) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178709 (CHEMBL3814683) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178713 (CHEMBL3815051) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 75 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178711 (CHEMBL3814176) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 85 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178717 (CHEMBL3815007) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 93 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178942 (CHEMBL3814546) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 111 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178708 (CHEMBL3814251) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 113 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178943 (CHEMBL3814577) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 207 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178707 (CHEMBL3814811) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 218 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of CCR9-mediated chemotaxis in human MOLT4 cells preincubated for 10 mins followed by TECK addition in presence of 0.1% BSA measured after... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178944 (CHEMBL3814185) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 232 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178703 (CHEMBL3814202) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 232 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178704 (CHEMBL3814736) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 277 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of CCR9-mediated chemotaxis in human MOLT4 cells preincubated for 10 mins followed by TECK addition in presence of 0.1% BSA measured after... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178706 (CHEMBL3814037) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 378 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178718 (CHEMBL3814598) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 451 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178708 (CHEMBL3814251) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 590 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of CCR9-mediated chemotaxis in human MOLT4 cells preincubated for 10 mins followed by TECK addition in presence of 0.1% BSA measured after... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178709 (CHEMBL3814683) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1.05E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of CCR9-mediated chemotaxis in human MOLT4 cells preincubated for 10 mins followed by TECK addition in presence of 0.1% BSA measured after... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178703 (CHEMBL3814202) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1.37E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of CCR9-mediated chemotaxis in human MOLT4 cells preincubated for 10 mins followed by TECK addition in presence of 0.1% BSA measured after... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178706 (CHEMBL3814037) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 2.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of CCR9-mediated chemotaxis in human MOLT4 cells preincubated for 10 mins followed by TECK addition in presence of 0.1% BSA measured after... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178705 (CHEMBL3814804) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 5.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of CCR9-mediated chemotaxis in human MOLT4 cells preincubated for 10 mins followed by TECK addition in presence of 0.1% BSA measured after... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178715 (CHEMBL3814368) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 8.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178710 (CHEMBL3815082) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-C chemokine receptor type 9 (Homo sapiens (Human)) | BDBM50178719 (CHEMBL3814735) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cubist Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at CCR9 (unknown origin) assessed as inhibition of TECK-stimulated calcium mobilization preincubated for 10 mins followed by agon... | Bioorg Med Chem Lett 26: 3322-3325 (2016) Article DOI: 10.1016/j.bmcl.2016.05.043 BindingDB Entry DOI: 10.7270/Q2PZ5BQX | |||||||||||
More data for this Ligand-Target Pair |